Antibodies are studied more than other immune proteins for association with disease. This does not mean that they are more decisive in disease outcomes. Type I interferon likely has far more impact. Antibodies Are Not the Whole Story of Immune Resilience Toward Cancer
Much is being made of a recent study showing IgG4 antibodies spiking in the blood labs of those who are triple-injected with the mRNA COVID vaccines.   Journalists are speculating that this may be the cause of increased cancers in the COVID-vaccinated.  But that is not the main reason that the COVID-vaccinated are getting new cancer cases, sometimes aggressive “turbo cancers,” or coming out of remission from earlier cancer.  Rather, there is earlier research that provides more plausible mechanisms for cancer risk, based on abundant prior knowledge of immune function.  Let’s look at both the new study on IgG antibodies and earlier research….